Health Economics and HTA and its role in pricing and reimbursement, pipeline and in-lisencing evaluations as well as portfolio and company valuations in the biotech and pharmaceutical sector is ever increasing. While I was searching the web for various news on the topic, I actually couldn't find a blog that offers a platform of exchange among professionals in this field around the various topics - so there we go now and I hope you enjoy the information...
Cheers
Ulf
Arrowhead-Spectra Conferences announces that it is hosting an Expert Opinion Conference on Pharmaceutical Pricing and Reimbursement at the Royal Society of Medicine, in Central London, UK on the 29th May, 2008
No comments:
Post a Comment